PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma—a proof of principle study

INTRODUCTION: Angiosarcoma is a rare and aggressive malignancy with a high metastatic potential and recurrence rate. Despite optimal treatment with surgery, with or without radiation, the prognosis remains poor and, therefore, new treatment strategies are warranted. Recently, propranolol has effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinhuis, Kimberley M, IJzerman, Nikki S, Koenen, Anne Miek, van der Graaf, Winette T A, Haas, Rick L, Beijnen, Jos H, Huitema, Alwin D R, van Houdt, Winan J, Steeghs, Neeltje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485254/
https://www.ncbi.nlm.nih.gov/pubmed/32912994
http://dx.doi.org/10.1136/bmjopen-2020-039449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485254/
https://www.ncbi.nlm.nih.gov/pubmed/32912994
http://dx.doi.org/10.1136/bmjopen-2020-039449

Ejemplares similares